| CTRI Number |
CTRI/2025/08/092728 [Registered on: 08/08/2025] Trial Registered Prospectively |
| Last Modified On: |
08/08/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Yoga & Naturopathy |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
This is a study of beneficial effects of yoga on the quality of life and stress in children who have experienced cancer and blood disorders and also their family members. |
|
Scientific Title of Study
|
Effect of yoga practice on health related quality of life at 12 weeks in paediatric haemat-oncological patients aged 3-18 years and their caregivers |
| Trial Acronym |
nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
K Prasanna Venkatesh |
| Designation |
PG resident 1st year |
| Affiliation |
ESIC PGIMSR Hospital |
| Address |
Pediatric hemato oncology division, Pediatric ward- unit II, first floor D3 Building, Pediatric Department, ESI PGIMSR Basaidarapur ,Ring road , New Delhi
New Delhi DELHI 110015 India |
| Phone |
9654411182 |
| Fax |
|
| Email |
drprasannaesic@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Kanwaljeet Kaur Chopra |
| Designation |
Senior Specialist & Associate Professor |
| Affiliation |
ESIC PGIMSR Hospital |
| Address |
Incharge Pediatric Hemato Oncology Division,
dept of Pediatrics,
ESI PGIMSR Basaidarapur ,Ring road , New Delhi
New Delhi DELHI 110015 India |
| Phone |
9899991596 |
| Fax |
|
| Email |
drkanwaljeetkaur@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
K Prasanna Venkatesh |
| Designation |
PG resident 1st year |
| Affiliation |
ESIC PGIMSR Hospital |
| Address |
Pediatric ward, Unit 2,
First floor, D3 Building,
Pediatric Hemato Oncology division,
Dept of Pediatrics,
ESI PGIMSR Basaidarapur ,Ring road , New Delhi
New Delhi DELHI 110015 India |
| Phone |
9654411182 |
| Fax |
|
| Email |
drprasannaesic@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
ESIC Basaidarapur |
| Address |
ESI PGIMSR Basaidarapur , Ring Road , New Delhi |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
| Name |
Address |
| NIL |
NIL |
| Not Applicable |
Not Applicable |
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| K Prasanna Venkatesh |
ESIC Hospital and PGIMSR Basaidarapur |
Paeditric ward unit 2 , 1st floor , D3 building , paediatric hematoncology division, Department of Paediatrics, ESI PGIMSR Ring Road , New Delhi West DELHI |
9654411182
drprasannaesic@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| IEC ESI-PGIMSR Basaidarapur |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: C812||Mixed cellularity Hodgkin lymphoma, (2) ICD-10 Condition: C910||Acute lymphoblastic leukemia [ALL], (3) ICD-10 Condition: C921||Chronic myeloid leukemia, BCR/ABL-positive, (4) ICD-10 Condition: C819||Hodgkin lymphoma, unspecified, (5) ICD-10 Condition: D561||Beta thalassemia, (6) ICD-10 Condition: D569||Thalassemia, unspecified, (7) ICD-10 Condition: D552||Anemia due to disorders of glycolytic enzymes, (8) ICD-10 Condition: D67||Hereditary factor IX deficiency, (9) ICD-10 Condition: D66||Hereditary factor VIII deficiency, (10) ICD-10 Condition: D693||Immune thrombocytopenic purpura, (11) ICD-10 Condition: D644||Congenital dyserythropoietic anemia, (12) ICD-10 Condition: C946||Myelodysplastic disease, not classified, (13) ICD-10 Condition: D648||Other specified anemias, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Comparator Not applicable |
Comparator not applicable |
| Intervention |
Yoga Practice for 12 weeks |
Patients and their caregivers will be asked to do personalized yoga as advised by certified yoga instructor in the hospital. The patients and their caregivers will practice yoga for 5 days a week for 10 or 30 minutes each day depending on the age and they will be keeping the daily log in a diary. It will be 3 times a week online followup by hospital visit of the patient every 3 weekly |
|
|
Inclusion Criteria
|
| Age From |
3.00 Year(s) |
| Age To |
18.00 Year(s) |
| Gender |
Both |
| Details |
Subjects diagnosed with oncological or chronic haematological conditions undergoing active treatment such as chemotherapy, radiotherapy, blood transfusions, factor replacement, chelation therapy, and post-treatment monitoring etc or survivors of childhood cancer conforming to the following
1 At least one parent or primary caregiver of each participating child is available
2 At least one caregiver and/or the child is able to comprehend the technique of yoga and respond to questionnaires.
|
|
| ExclusionCriteria |
| Details |
1 Patients with medical conditions or contraindications to physical activity such as hemodynamically unstable, dyselectrolytemia, febrile neutropenia, platelet count less than 50000 per µL or with bleeding, haemoglobin less than 7 g per dL, bone or soft tissue injury, tumour lysis syndrome, intercurrent infection etc
2 Severe cognitive or psychiatric disorder in child or primary caregiver that hinder participation.
3 Previous regular yoga practice in the patient or caregiver in last 6 months.
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Primary outcome is change in health related quality of life by PedsQOL 4.0 for patients and parents |
Baseline and at 12 weeks |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Secondary outcome is change in parental stress by perceived stress scale |
Baseline and at 12 weeks |
Change in child stress and anxiety by Revised Children’s Anxiety and depression
scale 25
|
Baseline and at 12 weeks |
|
|
Target Sample Size
|
Total Sample Size="80" Sample Size from India="80"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
19/08/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
19/08/2025 |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Study Design- Quasi experimental study Study duration- June 2025 to November 2026. Intervention period- 12-week period, with pre- and post-intervention assessments. Study Setting- The study will be conducted in the Paediatric haemato-oncology clinic and Paediatric ward in the Department of Paediatrics with a dedicated yoga instructor at the Employee State Insurance Corporation (ESIC) Model Hospital and PGIMSR, Basaidarapur, New Delhi in collaboration. Sample Size Taking
the study by Bisht et al as the parent study, the sample size will be determined
based on a power analysis, aiming to detect a moderate effect size (Cohen’s d =
0.5) with 80% power and a significance level of 0.05. A minimum of 40
patient-caregiver dyads ( a total of 80 subjects) will be enrolled, accounting for a 20% dropout rate.
Bisht et al studied the impact of yoga based
lifestyle intervention (YBLI) on psychological stress and quality of life in
the parents of children with retinoblastoma with a sample size of 86 (43 dyads
of both parents of retinoblastoma patients.) The study concluded that YBLI improves overall
health and QOL and reduces psychological stress experienced by the parents of
retinoblastoma patients. Sampling Technique A consecutive sampling method will be used. Eligible participants will be enrolled during routine outpatient or inpatient visits over a recruitment period of 15 months (leaving 3 months for follow-up). Intervention Participation will consist of practicing of yoga for 12 weeks, consisting of: Frequency of yoga practice is 5 sessions per week as per convenience of patients and parents at their home. Duration of yoga is 10-30 minutes per session (less than 10 years – 10 minutes; greater than10 years-30 minutes) . Patients will be asked to do Age-appropriate asanas (postures), pranayama (breathing exercises), and guided meditation. Sessions will be age and appropriate for disease stage. Sessions will be led by certified yoga therapist and will be taught to the parents. Monitoring of compliance by keeping record of diary daily and video calls 3 times per week and interviewed physically 3 weekly. Data Collection Demographic and clinical data (diagnosis, treatment phase, etc.) will be collected from medical records. Participants will complete questionnaires under supervision at two time points.. HRQoL assessments will be conducted at baseline (Week 0) and post-intervention (Week 12). If yoga is delayed due to any issue, the final assessment will be done at completion of 12 weeks of yoga therapy. Statistical Analysis The data collected will be entered in Microsoft Excel and the analyses will be done using Statistical Package for Social Sciences (SPSS) version 25.0. Descriptive statistics will be used to summarize the demographic and clinical variables. The discrete variables will be presented as frequency and percentages whereas the continuous variables will be presented as mean (SD) or median (IQR). Paired t-tests (or Wilcoxon signed-rank tests for non-parametric data) will be used to assess within-group differences. Independent t-tests (or Mann–Whitney U tests) will be used to compare between-group differences. Multivariate linear regression will be used to control for confounders (e.g., age, treatment type). Significance will be set at p less than 0.05.
|